NCT05824065Phase 3Not yet recruiting
Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
Phase III, National, Multicenter, Randomized, Double-Blind, Superiority Clinical Trial to Evaluate the Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
In the register
The register attaches this trial to OMA102 (EMS), currently at “Phase 3” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 3
- Sponsor
- EMS
- Participants (registry)
- 504
- Start
- January 2025 (planned)
- Primary completion
- January 2027 (planned)
- Study completion
- January 2027 (planned)
- Last registry update
- February 2024
- Countries
- Brazil
Conditions studied: Female Pattern Baldness
Interventions: OMA102, OMA102, Placebo
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.